Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

Authors: 
Zhao XY, Boyle B, Krishnan AV, Navone NM, Peehl DM, Feldman D

We have characterized the androgen receptor (AR) in a new human prostate cancer cell line, MDA PCa 2a, that has recently been established from a bone metastasis of a patient whose cancer exhibited androgen-independent growth.
